| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase activity | 9.55e-08 | 18 | 49 | 4 | GO:0004016 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 2.76e-07 | 6 | 49 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 2.76e-07 | 6 | 49 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | cyclase activity | 3.28e-07 | 24 | 49 | 4 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 3.90e-07 | 25 | 49 | 4 | GO:0016849 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 7.71e-07 | 8 | 49 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.15e-06 | 9 | 49 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 7.60e-06 | 16 | 49 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 1.54e-05 | 20 | 49 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | carbon dioxide transmembrane transporter activity | 3.53e-05 | 4 | 49 | 2 | GO:0035379 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 5.87e-05 | 5 | 49 | 2 | GO:0008294 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 3.83e-04 | 12 | 49 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 6.77e-04 | 70 | 49 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 7.03e-04 | 614 | 49 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.80e-04 | 18 | 49 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | ankyrin binding | 1.44e-03 | 23 | 49 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | lyase activity | 1.80e-03 | 212 | 49 | 4 | GO:0016829 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.14e-03 | 28 | 49 | 2 | GO:0051959 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.68e-03 | 775 | 49 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.04e-03 | 118 | 49 | 3 | GO:0003774 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.72e-03 | 37 | 49 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 4.15e-03 | 839 | 49 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 4.18e-03 | 840 | 49 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.18e-03 | 840 | 49 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 4.41e-03 | 441 | 49 | 5 | GO:0016887 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 5.31e-03 | 144 | 49 | 3 | GO:0140101 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors | 8.64e-03 | 57 | 49 | 2 | GO:0016667 | |
| GeneOntologyBiologicalProcess | ribonucleotide biosynthetic process | 1.11e-07 | 247 | 49 | 8 | GO:0009260 | |
| GeneOntologyBiologicalProcess | ribose phosphate biosynthetic process | 1.34e-07 | 253 | 49 | 8 | GO:0046390 | |
| GeneOntologyBiologicalProcess | amide biosynthetic process | 1.59e-07 | 172 | 49 | 7 | GO:0043604 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 2.41e-07 | 23 | 49 | 4 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 7.00e-07 | 8 | 49 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | nucleotide biosynthetic process | 7.79e-07 | 319 | 49 | 8 | GO:0009165 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate biosynthetic process | 7.98e-07 | 320 | 49 | 8 | GO:1901293 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.49e-06 | 10 | 49 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 1.49e-06 | 10 | 49 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 2.05e-06 | 11 | 49 | 3 | GO:0006171 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 2.05e-06 | 11 | 49 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 2.73e-06 | 12 | 49 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 3.56e-06 | 44 | 49 | 4 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 3.90e-06 | 45 | 49 | 4 | GO:0009187 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 6.90e-06 | 16 | 49 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 7.00e-06 | 52 | 49 | 4 | GO:1901570 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | 7.33e-06 | 736 | 49 | 10 | GO:1901137 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 1.40e-05 | 20 | 49 | 3 | GO:0006750 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 1.63e-05 | 21 | 49 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide biosynthetic process | 1.77e-05 | 232 | 49 | 6 | GO:0009152 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 1.88e-05 | 22 | 49 | 3 | GO:0019370 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 1.88e-05 | 22 | 49 | 3 | GO:0019184 | |
| GeneOntologyBiologicalProcess | icosanoid biosynthetic process | 1.93e-05 | 67 | 49 | 4 | GO:0046456 | |
| GeneOntologyBiologicalProcess | carboxylic acid biosynthetic process | 2.72e-05 | 374 | 49 | 7 | GO:0046394 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 2.79e-05 | 25 | 49 | 3 | GO:0046058 | |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 2.79e-05 | 25 | 49 | 3 | GO:0009070 | |
| GeneOntologyBiologicalProcess | organic acid biosynthetic process | 2.86e-05 | 377 | 49 | 7 | GO:0016053 | |
| GeneOntologyBiologicalProcess | carbon dioxide transmembrane transport | 3.31e-05 | 4 | 49 | 2 | GO:0035378 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 3.35e-05 | 533 | 49 | 8 | GO:0009259 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 3.67e-05 | 540 | 49 | 8 | GO:0019693 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 4.29e-05 | 82 | 49 | 4 | GO:1901568 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | 5.08e-05 | 280 | 49 | 6 | GO:0006164 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 5.50e-05 | 5 | 49 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | 5.94e-05 | 288 | 49 | 6 | GO:0072522 | |
| GeneOntologyBiologicalProcess | sulfur compound biosynthetic process | 6.34e-05 | 178 | 49 | 5 | GO:0044272 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 7.01e-05 | 767 | 49 | 9 | GO:0055086 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 7.16e-05 | 34 | 49 | 3 | GO:0043043 | |
| GeneOntologyBiologicalProcess | ammonium homeostasis | 8.24e-05 | 6 | 49 | 2 | GO:0097272 | |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 9.25e-05 | 37 | 49 | 3 | GO:0042219 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 1.17e-04 | 40 | 49 | 3 | GO:0000096 | |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | 1.26e-04 | 644 | 49 | 8 | GO:0090407 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.26e-04 | 41 | 49 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | serine family amino acid metabolic process | 1.45e-04 | 43 | 49 | 3 | GO:0009069 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 1.90e-04 | 684 | 49 | 8 | GO:0009117 | |
| GeneOntologyBiologicalProcess | amide metabolic process | 1.92e-04 | 511 | 49 | 7 | GO:0043603 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 2.04e-04 | 691 | 49 | 8 | GO:0006753 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 2.56e-04 | 130 | 49 | 4 | GO:0097306 | |
| GeneOntologyBiologicalProcess | modified amino acid biosynthetic process | 2.57e-04 | 52 | 49 | 3 | GO:0042398 | |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 2.71e-04 | 53 | 49 | 3 | GO:0044273 | |
| GeneOntologyBiologicalProcess | UMP biosynthetic process | 3.00e-04 | 11 | 49 | 2 | GO:0006222 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 3.59e-04 | 142 | 49 | 4 | GO:0006690 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside monophosphate biosynthetic process | 3.59e-04 | 12 | 49 | 2 | GO:0009174 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 4.24e-04 | 13 | 49 | 2 | GO:0072488 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 4.53e-04 | 63 | 49 | 3 | GO:0006749 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | 5.20e-04 | 1226 | 49 | 10 | GO:1901135 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 5.91e-04 | 69 | 49 | 3 | GO:0170038 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 6.17e-04 | 70 | 49 | 3 | GO:0170034 | |
| GeneOntologyBiologicalProcess | UMP metabolic process | 6.49e-04 | 16 | 49 | 2 | GO:0046049 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside monophosphate metabolic process | 7.35e-04 | 17 | 49 | 2 | GO:0009173 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 8.15e-04 | 77 | 49 | 3 | GO:1901607 | |
| GeneOntologyBiologicalProcess | Golgi to endosome transport | 8.26e-04 | 18 | 49 | 2 | GO:0006895 | |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 8.26e-04 | 18 | 49 | 2 | GO:1904322 | |
| GeneOntologyBiologicalProcess | response to forskolin | 9.21e-04 | 19 | 49 | 2 | GO:1904321 | |
| GeneOntologyBiologicalProcess | carbon dioxide transport | 9.21e-04 | 19 | 49 | 2 | GO:0015670 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate biosynthetic process | 9.21e-04 | 19 | 49 | 2 | GO:0009130 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 9.69e-04 | 185 | 49 | 4 | GO:0170039 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | 1.02e-03 | 676 | 49 | 7 | GO:0044283 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 1.05e-03 | 84 | 49 | 3 | GO:0006518 | |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 1.12e-03 | 86 | 49 | 3 | GO:0008652 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 1.29e-03 | 512 | 49 | 6 | GO:0009150 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | 1.31e-03 | 1142 | 49 | 9 | GO:0019637 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 1.49e-03 | 208 | 49 | 4 | GO:0170033 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide biosynthetic process | 1.60e-03 | 25 | 49 | 2 | GO:0009220 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 1.70e-03 | 365 | 49 | 5 | GO:0006790 | |
| GeneOntologyBiologicalProcess | gas transport | 1.73e-03 | 26 | 49 | 2 | GO:0015669 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleoside monophosphate metabolic process | 1.73e-03 | 26 | 49 | 2 | GO:0009129 | |
| GeneOntologyBiologicalProcess | spermatogenesis | 1.77e-03 | 744 | 49 | 7 | GO:0007283 | |
| GeneOntologyBiologicalProcess | multicellular organismal reproductive process | 1.78e-03 | 1194 | 49 | 9 | GO:0048609 | |
| GeneOntologyBiologicalProcess | male gamete generation | 2.03e-03 | 762 | 49 | 7 | GO:0048232 | |
| GeneOntologyBiologicalProcess | gamete generation | 2.04e-03 | 982 | 49 | 8 | GO:0007276 | |
| GeneOntologyBiologicalProcess | protein localization to Golgi apparatus | 2.62e-03 | 32 | 49 | 2 | GO:0034067 | |
| GeneOntologyBiologicalProcess | one-carbon compound transport | 2.79e-03 | 33 | 49 | 2 | GO:0019755 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleotide biosynthetic process | 2.79e-03 | 33 | 49 | 2 | GO:0006221 | |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | 2.82e-03 | 1035 | 49 | 8 | GO:0019752 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | 2.95e-03 | 251 | 49 | 4 | GO:1901605 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleotide metabolic process | 2.95e-03 | 34 | 49 | 2 | GO:0009218 | |
| GeneOntologyBiologicalProcess | activation of adenylate cyclase activity | 2.95e-03 | 34 | 49 | 2 | GO:0007190 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | 3.23e-03 | 1058 | 49 | 8 | GO:0043436 | |
| GeneOntologyBiologicalProcess | protein maturation | 3.33e-03 | 619 | 49 | 6 | GO:0051604 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 3.33e-03 | 619 | 49 | 6 | GO:0006163 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 3.34e-03 | 1064 | 49 | 8 | GO:0006082 | |
| GeneOntologyBiologicalProcess | sexual reproduction | 3.38e-03 | 1312 | 49 | 9 | GO:0019953 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 3.65e-03 | 130 | 49 | 3 | GO:1901655 | |
| GeneOntologyBiologicalProcess | ribonucleoside monophosphate biosynthetic process | 3.68e-03 | 38 | 49 | 2 | GO:0009156 | |
| MousePheno | abnormal circulating glutathione level | 2.16e-07 | 5 | 40 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 2.16e-07 | 5 | 40 | 3 | MP:0030653 | |
| MousePheno | increased glutathione level | 2.16e-07 | 5 | 40 | 3 | MP:0012606 | |
| MousePheno | glutathionuria | 2.16e-07 | 5 | 40 | 3 | MP:0013730 | |
| MousePheno | decreased circulating testosterone level | 7.21e-07 | 60 | 40 | 5 | MP:0002780 | |
| MousePheno | decreased circulating cysteine level | 7.54e-07 | 7 | 40 | 3 | MP:0030626 | |
| MousePheno | epididymis hypoplasia | 1.20e-06 | 8 | 40 | 3 | MP:0004932 | |
| MousePheno | decreased cysteine level | 1.20e-06 | 8 | 40 | 3 | MP:0030623 | |
| MousePheno | nervous | 1.80e-06 | 9 | 40 | 3 | MP:0008912 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 2.51e-06 | 34 | 40 | 4 | MP:0002790 | |
| MousePheno | failure of copulatory plug deposition | 2.57e-06 | 10 | 40 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 2.57e-06 | 10 | 40 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 2.57e-06 | 10 | 40 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 3.52e-06 | 11 | 40 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 3.52e-06 | 11 | 40 | 3 | MP:0011130 | |
| MousePheno | abnormal circulating testosterone level | 3.87e-06 | 84 | 40 | 5 | MP:0005180 | |
| MousePheno | abnormal circulating androgen level | 3.87e-06 | 84 | 40 | 5 | MP:0009819 | |
| MousePheno | abnormal testosterone level | 6.07e-06 | 92 | 40 | 5 | MP:0011385 | |
| MousePheno | abnormal cysteine level | 6.09e-06 | 13 | 40 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 6.09e-06 | 13 | 40 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 6.09e-06 | 13 | 40 | 3 | MP:0012603 | |
| MousePheno | decreased follicle stimulating hormone level | 7.18e-06 | 44 | 40 | 4 | MP:0005130 | |
| MousePheno | priapism | 7.73e-06 | 14 | 40 | 3 | MP:0003415 | |
| MousePheno | abnormal copulatory plug deposition | 1.18e-05 | 16 | 40 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 1.18e-05 | 16 | 40 | 3 | MP:0008477 | |
| MousePheno | failure of superovulation | 1.72e-05 | 18 | 40 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 1.72e-05 | 18 | 40 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 1.72e-05 | 18 | 40 | 3 | MP:0009093 | |
| MousePheno | abnormal copulation physiology | 2.04e-05 | 19 | 40 | 3 | MP:0031627 | |
| MousePheno | increased circulating growth hormone level | 2.04e-05 | 19 | 40 | 3 | MP:0005123 | |
| MousePheno | abnormal ovarian follicle number | 2.22e-05 | 203 | 40 | 6 | MP:0008871 | |
| MousePheno | decreased circulating gonadotropin level | 2.50e-05 | 60 | 40 | 4 | MP:0003363 | |
| MousePheno | small vertebrae | 3.22e-05 | 22 | 40 | 3 | MP:0004610 | |
| MousePheno | increased growth hormone level | 3.69e-05 | 23 | 40 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 3.69e-05 | 23 | 40 | 3 | MP:0001121 | |
| MousePheno | abnormal copulation behavior | 4.21e-05 | 24 | 40 | 3 | MP:0009697 | |
| MousePheno | small epididymis | 4.60e-05 | 70 | 40 | 4 | MP:0004930 | |
| MousePheno | nuclear cataract | 5.39e-05 | 26 | 40 | 3 | MP:0010254 | |
| MousePheno | abnormal ovarian follicle morphology | 6.35e-05 | 245 | 40 | 6 | MP:0001131 | |
| MousePheno | aminoaciduria | 7.53e-05 | 29 | 40 | 3 | MP:0003311 | |
| MousePheno | anovulation | 1.12e-04 | 33 | 40 | 3 | MP:0008869 | |
| MousePheno | decreased circulating pituitary hormone level | 1.18e-04 | 89 | 40 | 4 | MP:0005118 | |
| MousePheno | abnormal follicle stimulating hormone level | 1.18e-04 | 89 | 40 | 4 | MP:0003967 | |
| MousePheno | abnormal sexual interaction | 1.46e-04 | 94 | 40 | 4 | MP:0002566 | |
| MousePheno | decreased amino acid level | 1.64e-04 | 97 | 40 | 4 | MP:0014528 | |
| MousePheno | decreased circulating estradiol level | 1.71e-04 | 38 | 40 | 3 | MP:0005181 | |
| MousePheno | abnormal reproductive system development | 1.78e-04 | 99 | 40 | 4 | MP:0003936 | |
| MousePheno | decreased circulating amino acid level | 1.83e-04 | 187 | 40 | 5 | MP:0014531 | |
| MousePheno | decreased tertiary ovarian follicle number | 1.85e-04 | 39 | 40 | 3 | MP:0011129 | |
| MousePheno | decreased circulating estrogen level | 2.15e-04 | 41 | 40 | 3 | MP:0003371 | |
| MousePheno | induced hyperactivity | 2.31e-04 | 42 | 40 | 3 | MP:0008911 | |
| MousePheno | decreased long bone epiphyseal plate size | 2.65e-04 | 44 | 40 | 3 | MP:0006396 | |
| MousePheno | absent estrous cycle | 2.65e-04 | 44 | 40 | 3 | MP:0009009 | |
| MousePheno | abnormal circulating gonadotropin level | 2.86e-04 | 112 | 40 | 4 | MP:0003361 | |
| MousePheno | decreased pituitary hormone level | 2.96e-04 | 113 | 40 | 4 | MP:0003972 | |
| MousePheno | abnormal tertiary ovarian follicle number | 3.23e-04 | 47 | 40 | 3 | MP:0011127 | |
| MousePheno | abnormal corpus luteum morphology | 3.27e-04 | 116 | 40 | 4 | MP:0002679 | |
| MousePheno | decreased thyroxine level | 4.11e-04 | 51 | 40 | 3 | MP:0005471 | |
| MousePheno | abnormal circulating estradiol level | 4.35e-04 | 52 | 40 | 3 | MP:0005183 | |
| MousePheno | aciduria | 5.14e-04 | 55 | 40 | 3 | MP:0010028 | |
| MousePheno | abnormal circulating estrogen level | 5.71e-04 | 57 | 40 | 3 | MP:0003369 | |
| MousePheno | abnormal tertiary ovarian follicle morphology | 5.71e-04 | 57 | 40 | 3 | MP:0009363 | |
| MousePheno | disproportionate dwarf | 5.71e-04 | 57 | 40 | 3 | MP:0002427 | |
| MousePheno | abnormal growth hormone level | 5.71e-04 | 57 | 40 | 3 | MP:0003968 | |
| MousePheno | abnormal urine amino acid level | 6.31e-04 | 59 | 40 | 3 | MP:0011468 | |
| MousePheno | immotile sperm | 6.31e-04 | 59 | 40 | 3 | MP:0020869 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 6.96e-04 | 61 | 40 | 3 | MP:0004701 | |
| MousePheno | impaired ovarian folliculogenesis | 6.96e-04 | 61 | 40 | 3 | MP:0001129 | |
| MousePheno | diluted coat color | 8.01e-04 | 64 | 40 | 3 | MP:0000371 | |
| MousePheno | abnormal seminal vesicle size | 8.20e-04 | 148 | 40 | 4 | MP:0004907 | |
| MousePheno | abnormal female germ cell morphology | 8.62e-04 | 150 | 40 | 4 | MP:0006361 | |
| MousePheno | abnormal thyroxine level | 8.77e-04 | 66 | 40 | 3 | MP:0005469 | |
| MousePheno | abnormal superovulation | 8.77e-04 | 66 | 40 | 3 | MP:0009648 | |
| MousePheno | absent corpus luteum | 8.77e-04 | 66 | 40 | 3 | MP:0001134 | |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 9.56e-04 | 68 | 40 | 3 | MP:0003662 | |
| MousePheno | abnormal epididymis morphology | 9.64e-04 | 269 | 40 | 5 | MP:0002631 | |
| MousePheno | abnormal circulating insulin-like growth factor I level | 1.13e-03 | 72 | 40 | 3 | MP:0004700 | |
| MousePheno | abnormal thyroid hormone level | 1.22e-03 | 74 | 40 | 3 | MP:0005468 | |
| MousePheno | abnormal epididymis size | 1.26e-03 | 166 | 40 | 4 | MP:0004926 | |
| MousePheno | abnormal insulin-like growth factor I level | 1.27e-03 | 75 | 40 | 3 | MP:0008831 | |
| MousePheno | increased osteoclast cell number | 1.37e-03 | 77 | 40 | 3 | MP:0004984 | |
| MousePheno | abnormal circulating pituitary hormone level | 1.43e-03 | 172 | 40 | 4 | MP:0005116 | |
| MousePheno | hindlimb paralysis | 1.48e-03 | 79 | 40 | 3 | MP:0000755 | |
| MousePheno | abnormal ammonia homeostasis | 1.62e-03 | 21 | 40 | 2 | MP:0030604 | |
| MousePheno | small ovary | 1.62e-03 | 178 | 40 | 4 | MP:0001127 | |
| MousePheno | abnormal ovary morphology | 1.65e-03 | 451 | 40 | 6 | MP:0001126 | |
| MousePheno | limb paralysis | 1.70e-03 | 83 | 40 | 3 | MP:0013147 | |
| MousePheno | decreased locomotor activity | 2.09e-03 | 829 | 40 | 8 | MP:0001402 | |
| MousePheno | abnormal female reproductive gland morphology | 2.14e-03 | 475 | 40 | 6 | MP:0013324 | |
| MousePheno | abnormal circulating amino acid level | 2.28e-03 | 481 | 40 | 6 | MP:0005311 | |
| MousePheno | small uterus | 2.29e-03 | 92 | 40 | 3 | MP:0002637 | |
| MousePheno | abnormal ovulation | 2.66e-03 | 97 | 40 | 3 | MP:0001928 | |
| MousePheno | decreased bone mass | 2.90e-03 | 100 | 40 | 3 | MP:0004016 | |
| MousePheno | small gonad | 3.14e-03 | 885 | 40 | 8 | MP:0001116 | |
| MousePheno | abnormal pituitary hormone level | 3.17e-03 | 214 | 40 | 4 | MP:0003965 | |
| MousePheno | abnormal primary sex determination | 3.50e-03 | 901 | 40 | 8 | MP:0002211 | |
| MousePheno | small seminiferous tubules | 3.51e-03 | 107 | 40 | 3 | MP:0001153 | |
| MousePheno | asthenozoospermia | 3.54e-03 | 362 | 40 | 5 | MP:0002675 | |
| MousePheno | increased circulating pituitary hormone level | 3.79e-03 | 110 | 40 | 3 | MP:0005117 | |
| Domain | A/G_cyclase_CS | 7.49e-08 | 17 | 46 | 4 | IPR018297 | |
| Domain | Nucleotide_cyclase | 9.61e-08 | 18 | 46 | 4 | IPR029787 | |
| Domain | - | 9.61e-08 | 18 | 46 | 4 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.21e-07 | 19 | 46 | 4 | PS00452 | |
| Domain | Guanylate_cyc | 1.21e-07 | 19 | 46 | 4 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.21e-07 | 19 | 46 | 4 | PS50125 | |
| Domain | A/G_cyclase | 1.21e-07 | 19 | 46 | 4 | IPR001054 | |
| Domain | CYCc | 1.21e-07 | 19 | 46 | 4 | SM00044 | |
| Domain | AC_N | 7.76e-07 | 8 | 46 | 3 | IPR032628 | |
| Domain | Adcy | 7.76e-07 | 8 | 46 | 3 | IPR030672 | |
| Domain | AC_N | 7.76e-07 | 8 | 46 | 3 | PF16214 | |
| Domain | VPS13 | 1.78e-05 | 3 | 46 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 1.78e-05 | 3 | 46 | 2 | PF16910 | |
| Domain | VPS13 | 1.78e-05 | 3 | 46 | 2 | PF16908 | |
| Domain | VPS13_N2 | 1.78e-05 | 3 | 46 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 1.78e-05 | 3 | 46 | 2 | IPR031642 | |
| Domain | VPS13_C | 3.55e-05 | 4 | 46 | 2 | PF16909 | |
| Domain | SHR-BD | 3.55e-05 | 4 | 46 | 2 | IPR009543 | |
| Domain | VPS13_C | 3.55e-05 | 4 | 46 | 2 | IPR031645 | |
| Domain | SHR-BD | 3.55e-05 | 4 | 46 | 2 | PF06650 | |
| Domain | ATG_C | 5.91e-05 | 5 | 46 | 2 | PF09333 | |
| Domain | Ammonium_transpt | 5.91e-05 | 5 | 46 | 2 | IPR001905 | |
| Domain | Ammonium_transp | 5.91e-05 | 5 | 46 | 2 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 5.91e-05 | 5 | 46 | 2 | IPR024041 | |
| Domain | Autophagy-rel_C | 5.91e-05 | 5 | 46 | 2 | IPR015412 | |
| Domain | RhesusRHD | 5.91e-05 | 5 | 46 | 2 | IPR002229 | |
| Domain | Adcy_conserved_dom | 8.85e-05 | 6 | 46 | 2 | IPR009398 | |
| Domain | DUF1053 | 8.85e-05 | 6 | 46 | 2 | PF06327 | |
| Domain | GGT_peptidase | 1.24e-04 | 7 | 46 | 2 | IPR000101 | |
| Domain | G_GLU_TRANSPEPTIDASE | 1.24e-04 | 7 | 46 | 2 | PS00462 | |
| Domain | - | 1.24e-04 | 7 | 46 | 2 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 1.24e-04 | 7 | 46 | 2 | IPR029020 | |
| Domain | G_glu_transpept | 1.24e-04 | 7 | 46 | 2 | PF01019 | |
| Domain | VPS13_N | 1.65e-04 | 8 | 46 | 2 | IPR026854 | |
| Domain | Chorein_N | 1.65e-04 | 8 | 46 | 2 | PF12624 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.30e-04 | 14 | 46 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.30e-04 | 14 | 46 | 2 | IPR024743 | |
| Domain | MT | 5.30e-04 | 14 | 46 | 2 | PF12777 | |
| Domain | AAA_8 | 5.30e-04 | 14 | 46 | 2 | PF12780 | |
| Domain | DHC_fam | 6.11e-04 | 15 | 46 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 6.11e-04 | 15 | 46 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 6.11e-04 | 15 | 46 | 2 | PF03028 | |
| Domain | - | 8.85e-04 | 18 | 46 | 2 | 3.30.470.20 | |
| Domain | ATP_grasp_subdomain_2 | 2.64e-03 | 31 | 46 | 2 | IPR013816 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 2.84e-07 | 22 | 37 | 4 | MM15961 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.97e-06 | 10 | 37 | 3 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 1.97e-06 | 10 | 37 | 3 | MM14668 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 5.94e-06 | 14 | 37 | 3 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 5.94e-06 | 14 | 37 | 3 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 7.41e-06 | 15 | 37 | 3 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 7.41e-06 | 15 | 37 | 3 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 7.41e-06 | 15 | 37 | 3 | M47504 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 8.62e-06 | 108 | 37 | 5 | M17034 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 9.10e-06 | 16 | 37 | 3 | M39849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 9.10e-06 | 16 | 37 | 3 | M47645 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 9.10e-06 | 16 | 37 | 3 | MM14680 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 9.10e-06 | 16 | 37 | 3 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 9.10e-06 | 16 | 37 | 3 | MM14492 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 1.10e-05 | 17 | 37 | 3 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.10e-05 | 17 | 37 | 3 | M47544 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.84e-05 | 20 | 37 | 3 | M759 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 3.24e-05 | 24 | 37 | 3 | MM17249 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.24e-05 | 24 | 37 | 3 | M47520 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 3.68e-05 | 25 | 37 | 3 | MM14858 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 4.15e-05 | 26 | 37 | 3 | M47553 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 4.15e-05 | 26 | 37 | 3 | MM15190 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 4.15e-05 | 26 | 37 | 3 | MM14495 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 4.66e-05 | 27 | 37 | 3 | MM15908 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 4.66e-05 | 27 | 37 | 3 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 4.66e-05 | 27 | 37 | 3 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 5.21e-05 | 28 | 37 | 3 | M47647 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.80e-05 | 29 | 37 | 3 | M47515 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 5.80e-05 | 29 | 37 | 3 | M47627 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 7.11e-05 | 31 | 37 | 3 | M47507 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 7.67e-05 | 170 | 37 | 5 | MM15573 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 7.83e-05 | 32 | 37 | 3 | M47506 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 8.60e-05 | 33 | 37 | 3 | MM15058 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 8.60e-05 | 33 | 37 | 3 | MM15963 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 8.60e-05 | 33 | 37 | 3 | M11575 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.03e-04 | 35 | 37 | 3 | M47969 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 1.03e-04 | 35 | 37 | 3 | MM15815 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.22e-04 | 37 | 37 | 3 | M749 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 1.32e-04 | 38 | 37 | 3 | MM14600 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.43e-04 | 39 | 37 | 3 | MM15695 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.43e-04 | 39 | 37 | 3 | MM14496 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.66e-04 | 41 | 37 | 3 | M512 | |
| Pathway | REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION | 1.86e-04 | 8 | 37 | 2 | M26991 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.91e-04 | 43 | 37 | 3 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.91e-04 | 43 | 37 | 3 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.91e-04 | 43 | 37 | 3 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 2.05e-04 | 44 | 37 | 3 | MM15709 | |
| Pathway | REACTOME_GPER1_SIGNALING | 2.19e-04 | 45 | 37 | 3 | M45008 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 2.34e-04 | 46 | 37 | 3 | M39828 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 2.65e-04 | 48 | 37 | 3 | M10775 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 3.37e-04 | 52 | 37 | 3 | M920 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 3.76e-04 | 54 | 37 | 3 | M26911 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 3.98e-04 | 55 | 37 | 3 | M39763 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 4.04e-04 | 134 | 37 | 4 | M29840 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 5.14e-04 | 60 | 37 | 3 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 5.14e-04 | 60 | 37 | 3 | MM15708 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 5.39e-04 | 61 | 37 | 3 | MM14861 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.74e-04 | 147 | 37 | 4 | MM15854 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 5.93e-04 | 63 | 37 | 3 | M8 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 6.35e-04 | 151 | 37 | 4 | M39329 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 6.50e-04 | 65 | 37 | 3 | M15 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 6.83e-04 | 154 | 37 | 4 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 7.17e-04 | 156 | 37 | 4 | M39475 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 7.35e-04 | 157 | 37 | 4 | M4904 | |
| Pathway | KEGG_PURINE_METABOLISM | 7.70e-04 | 159 | 37 | 4 | M14314 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 8.41e-04 | 71 | 37 | 3 | MM14491 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 8.84e-04 | 165 | 37 | 4 | M39400 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 1.00e-03 | 620 | 37 | 7 | MM15193 | |
| Pathway | WP_PURINE_METABOLISM | 1.01e-03 | 171 | 37 | 4 | MM15909 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 1.33e-03 | 184 | 37 | 4 | MM15943 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 1.42e-03 | 85 | 37 | 3 | M3578 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 1.43e-03 | 188 | 37 | 4 | M4844 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 1.50e-03 | 22 | 37 | 2 | M39440 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 1.64e-03 | 23 | 37 | 2 | MM15885 | |
| Pathway | KEGG_GAP_JUNCTION | 1.67e-03 | 90 | 37 | 3 | M4013 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.67e-03 | 90 | 37 | 3 | M6467 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 1.67e-03 | 90 | 37 | 3 | MM15882 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 1.67e-03 | 90 | 37 | 3 | M835 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 1.73e-03 | 91 | 37 | 3 | M39426 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 1.78e-03 | 92 | 37 | 3 | MM15823 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.95e-03 | 95 | 37 | 3 | M29842 | |
| Pathway | KEGG_MELANOGENESIS | 2.32e-03 | 101 | 37 | 3 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.32e-03 | 101 | 37 | 3 | M1979 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 2.50e-03 | 219 | 37 | 4 | M29836 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.60e-03 | 105 | 37 | 3 | MM15206 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 2.60e-03 | 29 | 37 | 2 | M39676 | |
| Pathway | WP_LIPID_METABOLISM_PATHWAY | 2.60e-03 | 29 | 37 | 2 | M39762 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 2.74e-03 | 107 | 37 | 3 | MM14595 | |
| Pathway | WP_THERMOGENESIS | 2.81e-03 | 108 | 37 | 3 | M39746 | |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 3.16e-03 | 32 | 37 | 2 | MM15446 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.20e-03 | 113 | 37 | 3 | M27471 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 3.20e-03 | 113 | 37 | 3 | M16817 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.36e-03 | 115 | 37 | 3 | M9387 | |
| Pathway | REACTOME_DRUG_ADME | 3.70e-03 | 119 | 37 | 3 | MM15692 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.03e-03 | 250 | 37 | 4 | M27554 | |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 4.21e-03 | 37 | 37 | 2 | M729 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 5.48e-03 | 137 | 37 | 3 | MM15182 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 6.29e-03 | 144 | 37 | 3 | MM14501 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 7.04e-03 | 150 | 37 | 3 | M27440 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 2.97e-09 | 3 | 51 | 3 | 2573352 | |
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 2.96e-08 | 5 | 51 | 3 | 18063838 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 10940879 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 2.96e-08 | 5 | 51 | 3 | 12468440 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 2.96e-08 | 5 | 51 | 3 | 12225953 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 7775425 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 2.96e-08 | 5 | 51 | 3 | 11095909 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 7641802 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 23615310 | ||
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 2.96e-08 | 5 | 51 | 3 | 8566783 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 30591459 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 9139708 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 20622017 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 9627710 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 2.96e-08 | 5 | 51 | 3 | 9546365 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 12453183 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 11795900 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 7485380 | ||
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 11003618 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 2.96e-08 | 5 | 51 | 3 | 10751614 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 10392451 | ||
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 2.96e-08 | 5 | 51 | 3 | 7523374 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 2891746 | ||
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 2.96e-08 | 5 | 51 | 3 | 24698228 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 19850887 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 2.96e-08 | 5 | 51 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 2.96e-08 | 5 | 51 | 3 | 19760322 | |
| Pubmed | 2.96e-08 | 5 | 51 | 3 | 10474818 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 2.96e-08 | 5 | 51 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 2.96e-08 | 5 | 51 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 2.96e-08 | 5 | 51 | 3 | 11089562 | |
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 12163373 | ||
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 14634009 | ||
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 17363454 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 5.92e-08 | 6 | 51 | 3 | 8101000 | |
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 8663190 | ||
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 5.92e-08 | 6 | 51 | 3 | 8104871 | |
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 11463821 | ||
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 22242126 | ||
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 25326709 | ||
| Pubmed | 1.04e-07 | 7 | 51 | 3 | 27775020 | ||
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 1.04e-07 | 7 | 51 | 3 | 1968405 | |
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 1.04e-07 | 7 | 51 | 3 | 32284594 | |
| Pubmed | 1.04e-07 | 7 | 51 | 3 | 36685533 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 2.48e-07 | 9 | 51 | 3 | 17229090 | |
| Pubmed | 2.48e-07 | 9 | 51 | 3 | 12503609 | ||
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 3.54e-07 | 10 | 51 | 3 | 8663304 | |
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 3.54e-07 | 10 | 51 | 3 | 11884542 | |
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 16615126 | ||
| Pubmed | 3.54e-07 | 10 | 51 | 3 | 23863468 | ||
| Pubmed | 4.86e-07 | 11 | 51 | 3 | 10089566 | ||
| Pubmed | 4.86e-07 | 11 | 51 | 3 | 10808179 | ||
| Pubmed | 6.47e-07 | 12 | 51 | 3 | 10807185 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 1.07e-06 | 14 | 51 | 3 | 14993377 | |
| Pubmed | 1.07e-06 | 14 | 51 | 3 | 18357469 | ||
| Pubmed | 1.64e-06 | 16 | 51 | 3 | 17567809 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 37904480 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25180444 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23886516 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 23682772 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12846905 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 12204676 | ||
| Pubmed | Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C. | 2.11e-06 | 2 | 51 | 2 | 17196930 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 1417776 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 29674645 | ||
| Pubmed | The challenge of understanding ammonium homeostasis and the role of the Rh glycoproteins. | 2.11e-06 | 2 | 51 | 2 | 16564724 | |
| Pubmed | The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. | 2.11e-06 | 2 | 51 | 2 | 11062476 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 25280803 | ||
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 2.39e-06 | 18 | 51 | 3 | 17097888 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 2.90e-06 | 272 | 51 | 6 | 25315684 | |
| Pubmed | 5.09e-06 | 300 | 51 | 6 | 28561026 | ||
| Pubmed | Mechanisms of ammonia and ammonium transport by rhesus-associated glycoproteins. | 6.32e-06 | 3 | 51 | 2 | 26354748 | |
| Pubmed | VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. | 6.32e-06 | 3 | 51 | 2 | 30093493 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21726077 | ||
| Pubmed | Relative CO₂/NH₃ permeabilities of human RhAG, RhBG and RhCG. | 6.32e-06 | 3 | 51 | 2 | 24077989 | |
| Pubmed | TBC1D1 interacting proteins, VPS13A and VPS13C, regulate GLUT4 homeostasis in C2C12 myotubes. | 6.32e-06 | 3 | 51 | 2 | 33087848 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 21281598 | ||
| Pubmed | ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate. | 6.32e-06 | 3 | 51 | 2 | 26452058 | |
| Pubmed | Variation in Cilia Protein Genes and Progression of Lung Disease in Cystic Fibrosis. | 6.32e-06 | 3 | 51 | 2 | 29323929 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15929723 | ||
| Pubmed | 8.48e-06 | 27 | 51 | 3 | 18478268 | ||
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 1.06e-05 | 29 | 51 | 3 | 22424930 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.10e-05 | 736 | 51 | 8 | 29676528 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 15498460 | ||
| Pubmed | Transport characteristics of mammalian Rh and Rh glycoproteins expressed in heterologous systems. | 1.26e-05 | 4 | 51 | 2 | 16563829 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 22956255 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 21789219 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 12719424 | ||
| Pubmed | Acetyl-CoA carboxylase 1 is a suppressor of the adipocyte thermogenic program. | 2.10e-05 | 5 | 51 | 2 | 37163372 | |
| Pubmed | Evolutionary conservation and diversification of Rh family genes and proteins. | 2.10e-05 | 5 | 51 | 2 | 16227429 | |
| Pubmed | Cloning and nucleotide sequence of human gamma-glutamyl transpeptidase. | 2.10e-05 | 5 | 51 | 2 | 2904146 | |
| Pubmed | Expression of multiple gamma-glutamyltransferase genes in man. | 2.10e-05 | 5 | 51 | 2 | 7906515 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.29e-05 | 1353 | 51 | 10 | 29467282 | |
| Pubmed | 2.42e-05 | 38 | 51 | 3 | 27820600 | ||
| Pubmed | 2.78e-05 | 241 | 51 | 5 | 23125841 | ||
| Pubmed | Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. | 3.15e-05 | 6 | 51 | 2 | 20081857 | |
| Pubmed | A novel transgenic mouse model of lysosomal storage disorder. | 3.15e-05 | 6 | 51 | 2 | 27659423 | |
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 3.15e-05 | 6 | 51 | 2 | 7766992 | |
| Interaction | FGF14 interactions | 4.42e-08 | 42 | 47 | 5 | int:FGF14 | |
| Interaction | GGT2P interactions | 1.59e-05 | 3 | 47 | 2 | int:GGT2P | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 3.54e-07 | 10 | 27 | 3 | 53 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 8.41e-07 | 13 | 27 | 3 | 564 | |
| GeneFamily | Dyneins, axonemal | 2.88e-04 | 17 | 27 | 2 | 536 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_DN | 2.41e-06 | 199 | 51 | 6 | M4821 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 2.41e-06 | 199 | 51 | 6 | M6651 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP | 3.95e-05 | 196 | 51 | 5 | M5313 | |
| Coexpression | LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB | 6.18e-05 | 353 | 51 | 6 | M39229 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 6.53e-05 | 111 | 51 | 4 | MM1111 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-06 | 187 | 51 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| Drug | AC1L8VEV | 2.30e-07 | 24 | 51 | 4 | CID000433433 | |
| Drug | AC1L1EV8 | 5.88e-07 | 8 | 51 | 3 | CID000002964 | |
| Drug | AC1NPJ0Q | 6.61e-07 | 74 | 51 | 5 | CID005159167 | |
| Drug | 14,15-dihydroforskolin | 8.81e-07 | 9 | 51 | 3 | CID000194193 | |
| Drug | 2',5'-dd3'-FSBA | 1.26e-06 | 10 | 51 | 3 | CID003081206 | |
| Drug | NC-5Z | 1.26e-06 | 10 | 51 | 3 | CID003035914 | |
| Drug | AC1NY9KD | 1.73e-06 | 11 | 51 | 3 | CID005771741 | |
| Drug | AC1L40QM | 1.73e-06 | 11 | 51 | 3 | CID000099213 | |
| Drug | B-Mlvp | 1.73e-06 | 11 | 51 | 3 | CID000195648 | |
| Drug | FCE 23884 | 2.98e-06 | 13 | 51 | 3 | CID000065898 | |
| Drug | AC1L1BJN | 2.98e-06 | 13 | 51 | 3 | CID000001467 | |
| Drug | nantradol hydrochloride | 2.98e-06 | 13 | 51 | 3 | CID000047652 | |
| Drug | sclareol glycol | 2.98e-06 | 13 | 51 | 3 | CID000091915 | |
| Drug | pyruvic acid | 4.28e-06 | 424 | 51 | 8 | CID000001060 | |
| Drug | SKF 38393 | 4.73e-06 | 110 | 51 | 5 | CID000001242 | |
| Drug | SKF 75670 | 4.73e-06 | 15 | 51 | 3 | CID000173870 | |
| Drug | BMY 42393 | 4.73e-06 | 15 | 51 | 3 | CID000131961 | |
| Drug | AC1L2AAS | 4.73e-06 | 15 | 51 | 3 | CID000068714 | |
| Drug | NSC97113 | 5.16e-06 | 51 | 51 | 4 | CID000001869 | |
| Drug | exemestane; Down 200; 0.01uM; MCF7; HG-U133A | 5.37e-06 | 199 | 51 | 6 | 165_DN | |
| Drug | U754 | 7.04e-06 | 17 | 51 | 3 | CID000062824 | |
| Drug | fentanyl isothiocyanate | 7.04e-06 | 17 | 51 | 3 | CID000084008 | |
| Drug | San 21009 | 7.04e-06 | 17 | 51 | 3 | CID000152662 | |
| Drug | Ro 41-9067 | 1.00e-05 | 19 | 51 | 3 | CID000125800 | |
| Drug | AC1L3XQA | 1.00e-05 | 19 | 51 | 3 | CID000124009 | |
| Drug | SK&F 82958 | 1.00e-05 | 19 | 51 | 3 | ctd:C071262 | |
| Drug | iohexol | 1.06e-05 | 61 | 51 | 4 | CID000003730 | |
| Drug | d 1b | 1.13e-05 | 62 | 51 | 4 | CID000449090 | |
| Drug | Dvdavp | 1.18e-05 | 20 | 51 | 3 | CID006441676 | |
| Drug | YM435 | 1.18e-05 | 20 | 51 | 3 | CID000132119 | |
| Drug | CAS 66104-23-2 | 1.21e-05 | 63 | 51 | 4 | CID000004745 | |
| Drug | 6-fluoronorepinephrine | 1.37e-05 | 21 | 51 | 3 | CID000001862 | |
| Drug | reproterol | 1.37e-05 | 21 | 51 | 3 | CID000025654 | |
| Drug | MDL-12330A | 1.45e-05 | 66 | 51 | 4 | CID000004024 | |
| Drug | GSK835726 | 1.58e-05 | 22 | 51 | 3 | CID005311268 | |
| Drug | beta-CNA | 1.82e-05 | 23 | 51 | 3 | CID005486190 | |
| Drug | Scpb | 1.82e-05 | 23 | 51 | 3 | CID000123843 | |
| Drug | 3'-AMP | 2.05e-05 | 72 | 51 | 4 | CID000041211 | |
| Drug | Brij 35 | 2.05e-05 | 72 | 51 | 4 | CID000024750 | |
| Drug | NAIN | 2.07e-05 | 24 | 51 | 3 | CID000195228 | |
| Drug | TL-99 | 2.07e-05 | 24 | 51 | 3 | CID000122132 | |
| Drug | DEPX | 2.07e-05 | 24 | 51 | 3 | CID000001328 | |
| Drug | trimetoquinol | 2.07e-05 | 24 | 51 | 3 | CID000005581 | |
| Drug | AC1L9NB5 | 2.35e-05 | 25 | 51 | 3 | CID000449609 | |
| Drug | PD 81,723 | 2.35e-05 | 25 | 51 | 3 | CID000122028 | |
| Drug | N-n-propylnorapomorphine | 2.35e-05 | 25 | 51 | 3 | CID000030137 | |
| Drug | tiotidine | 2.35e-05 | 25 | 51 | 3 | CID000050287 | |
| Drug | octimibate | 2.35e-05 | 25 | 51 | 3 | CID000065676 | |
| Drug | manganese-ATP | 2.35e-05 | 25 | 51 | 3 | CID000124341 | |
| Drug | Mp2589 | 2.41e-05 | 75 | 51 | 4 | CID003073497 | |
| Drug | 7B-forskolin | 2.65e-05 | 26 | 51 | 3 | CID000130638 | |
| Drug | metaproterenol | 2.65e-05 | 26 | 51 | 3 | CID000004086 | |
| Drug | RU 24926 | 2.98e-05 | 27 | 51 | 3 | CID000122203 | |
| Drug | SM-10906 | 2.98e-05 | 27 | 51 | 3 | CID006442261 | |
| Drug | tetrahydrofurfuryl alcohol | 3.33e-05 | 28 | 51 | 3 | CID000007360 | |
| Drug | butoxamine | 3.33e-05 | 28 | 51 | 3 | CID000018026 | |
| Drug | prenalterol | 3.33e-05 | 28 | 51 | 3 | CID000042396 | |
| Drug | desacetylnantradol | 3.33e-05 | 28 | 51 | 3 | CID000125211 | |
| Drug | Nocloprostum | 3.33e-05 | 28 | 51 | 3 | CID006435380 | |
| Drug | NSC755875 | 3.38e-05 | 165 | 51 | 5 | CID000002215 | |
| Drug | DPDPE | 3.43e-05 | 82 | 51 | 4 | CID000104787 | |
| Drug | 2 pN | 3.43e-05 | 82 | 51 | 4 | CID000122874 | |
| Drug | benzyl alcohol | 3.60e-05 | 83 | 51 | 4 | CID000000244 | |
| Drug | 1 Em | 3.60e-05 | 83 | 51 | 4 | CID000446621 | |
| Drug | motapizone | 3.71e-05 | 29 | 51 | 3 | CID000065819 | |
| Drug | AMMN | 3.71e-05 | 29 | 51 | 3 | CID000042016 | |
| Drug | tolazoline | 3.71e-05 | 29 | 51 | 3 | CID000005504 | |
| Drug | etazolate | 3.71e-05 | 29 | 51 | 3 | CID000003277 | |
| Drug | dihydroalprenolol | 4.12e-05 | 30 | 51 | 3 | CID000043216 | |
| Drug | AC1N2DGT | 4.12e-05 | 30 | 51 | 3 | CID004045015 | |
| Drug | PNU-107859 | 4.35e-05 | 174 | 51 | 5 | CID004369084 | |
| Drug | zinterol | 4.55e-05 | 31 | 51 | 3 | CID000037989 | |
| Drug | AC1L3P1W | 4.55e-05 | 31 | 51 | 3 | CID000119574 | |
| Drug | barbiturate | 5.02e-05 | 32 | 51 | 3 | CID000006211 | |
| Drug | RU 24969 | 5.02e-05 | 32 | 51 | 3 | CID000108028 | |
| Drug | dopexamine | 5.02e-05 | 32 | 51 | 3 | CID000055483 | |
| Drug | N6-monobutyryl-cAMP | 5.51e-05 | 33 | 51 | 3 | CID000115029 | |
| Drug | Depixol | 5.51e-05 | 33 | 51 | 3 | CID000017011 | |
| Drug | iodocyanopindolol | 5.51e-05 | 33 | 51 | 3 | CID000068618 | |
| Drug | metiamide | 5.51e-05 | 33 | 51 | 3 | CID001548992 | |
| Drug | 6,7-ADTN | 5.51e-05 | 33 | 51 | 3 | CID000003153 | |
| Drug | phosphonate analog | 5.51e-05 | 33 | 51 | 3 | CID000475766 | |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; HL60; HG-U133A | 5.67e-05 | 184 | 51 | 5 | 1393_DN | |
| Drug | 1,3-DCG | 5.87e-05 | 94 | 51 | 4 | CID000150911 | |
| Drug | zardaverine | 6.59e-05 | 35 | 51 | 3 | CID000005723 | |
| Drug | AC1L1DSZ | 7.18e-05 | 36 | 51 | 3 | CID000002494 | |
| Drug | chlorthalidone | 7.18e-05 | 36 | 51 | 3 | CID000002732 | |
| Drug | enprofylline | 7.18e-05 | 36 | 51 | 3 | CID000001676 | |
| Drug | practolol | 7.80e-05 | 37 | 51 | 3 | CID000004883 | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; HL60; HG-U133A | 7.84e-05 | 197 | 51 | 5 | 1551_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; HL60; HG-U133A | 7.84e-05 | 197 | 51 | 5 | 1750_DN | |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 2054_DN | |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; PC3; HT_HG-U133A | 8.03e-05 | 198 | 51 | 5 | 6362_DN | |
| Drug | 5 alpha-dihydrotestosterone | 8.19e-05 | 323 | 51 | 6 | CID000000015 | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; PC3; HT_HG-U133A | 8.22e-05 | 199 | 51 | 5 | 5859_DN | |
| Drug | 2g6p | 8.45e-05 | 38 | 51 | 3 | CID002740174 | |
| Drug | AC1L1XPX | 8.45e-05 | 38 | 51 | 3 | CID000011606 | |
| Drug | bicarbonate | 8.47e-05 | 325 | 51 | 6 | CID000000767 | |
| Drug | N6-cyclohexyladenosine | 9.87e-05 | 40 | 51 | 3 | CID000002692 | |
| Drug | Lopac-S-1316 | 9.87e-05 | 40 | 51 | 3 | CID003086457 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.32e-07 | 7 | 47 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 2.11e-07 | 8 | 47 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 2.48e-06 | 2 | 47 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 2.48e-06 | 2 | 47 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 7.44e-06 | 3 | 47 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 7.44e-06 | 3 | 47 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 6.91e-05 | 8 | 47 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | glucose tolerance test | 8.50e-04 | 27 | 47 | 2 | EFO_0004307 | |
| Disease | L-arginine measurement | 8.50e-04 | 27 | 47 | 2 | EFO_0006524 | |
| Disease | peptic ulcer disease | 1.27e-03 | 33 | 47 | 2 | MONDO_0004247 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 2.02e-03 | 157 | 47 | 3 | DOID:14330 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPRAGGVGGKRGVTA | 101 | A6NKX1 | |
| VVVGRARLGGIPVGV | 1971 | Q13085 | |
| GINHGPVIAGVIGAR | 991 | P51828 | |
| KIGLNIGPVVAGVIG | 1176 | O95622 | |
| RGGVEEGPTVLRKAG | 21 | P05089 | |
| PVGNAKRGKVFIVGG | 41 | Q7Z6M1 | |
| QKGGLSVAVPGEIRG | 126 | A6NGU5 | |
| GTVRAQIGGKLVPAG | 216 | Q9UPT6 | |
| GKATRVGGEPGITRA | 171 | Q9BT17 | |
| RIVGGKEIPGHSGEI | 4516 | Q9Y6V0 | |
| LPRAGGVGGKRGVTA | 101 | Q8IWN6 | |
| RGIISPVGGAKGART | 1281 | O75037 | |
| VLVRGLVLPVGGGSA | 221 | Q71SY5 | |
| FGKPLGIRTVAVIGG | 491 | Q9BUQ8 | |
| VGVVAGGGRIDKPIL | 166 | P62917 | |
| GVDVLPKIIQTVGGG | 326 | Q2PPJ7 | |
| GPRSTAGGVALAVVV | 36 | Q13724 | |
| RVGINVGPVVAGVIG | 976 | Q08828 | |
| LVGPTGGGKTTVYRI | 1751 | Q9C0G6 | |
| RILGVGISTGGRVNP | 466 | Q9Y223 | |
| VKETGVTLVGRPRGA | 391 | I3L273 | |
| IGLHSGPVVAGVVGL | 981 | P51841 | |
| AILGGPGTVQGVVRF | 91 | O14618 | |
| VGPTGGGKTTVRRIL | 1426 | Q0VDD8 | |
| RPAGKGAIIGFIKVG | 86 | Q5SQI0 | |
| VIFQGIEGKIRAGGP | 416 | Q8WUQ7 | |
| VPEGQTIKGRVGTVG | 336 | P43250 | |
| QKGGLSVAVPGEIRG | 126 | P36268 | |
| PVKGRGIRILSIDGG | 436 | Q9NP80 | |
| GKGGVVIAIPFSLVG | 196 | Q14D33 | |
| RVAVLGAPGVGKTAI | 6 | Q92737 | |
| TIIRIGTSGGIGIAP | 141 | O95045 | |
| VKPTRGEGVGVIGVI | 351 | Q8TE76 | |
| ALTQGRVPIIGVGGV | 321 | Q02127 | |
| RVLESKSVVPGGGAV | 401 | P17987 | |
| LGGSIVKGGPVQVLE | 351 | Q13228 | |
| IPLGKGRAGRVESGQ | 6 | Q6ZUB1 | |
| KGVTIIGPATVGGIK | 616 | P53396 | |
| KGVGKGLVGAVARPT | 2996 | Q96RL7 | |
| GLVGAVARPTGGIID | 3001 | Q96RL7 | |
| ITGSSIIGGGVKAPR | 71 | Q99437 | |
| GSLGKGIREPVSVGT | 1031 | Q8IX01 | |
| VVRVVGGGGQLLRPA | 76 | A0A6I8PU40 | |
| GVPKAVVVLTGGRGA | 631 | Q5GFL6 | |
| LPGVVGGLAGIVAVA | 336 | Q02094 | |
| GGGGGPRVVRIVKSE | 36 | Q96L92 | |
| RGVVGGVTGIITKPV | 3526 | Q709C8 | |
| IPGIIGGIVGAVTAA | 346 | Q9UBD6 | |
| IKAVSGAIVAQRGPG | 281 | Q9HB21 | |
| RGTVVAQGGGRALIP | 681 | Q9H3U1 | |
| QKGGLSVAVPGEIRG | 126 | P19440 | |
| AKGLESIRVTGPGGV | 101 | Q9H9Z2 |